Investigation to Understand and Optimize Psilocybin
RecruitingNCT06512194Phase: PHASE2Started 2025-05-13
Summary
This study will examine the effects of a single dose of psilocybin, administered with psychological support, on symptoms of depression. It will also assess whether different post-dosing interventions,
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
70 Years
Locations
Vail Health Behavioral HealthEdwards, Colorado, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06512194